MRK vs. MSTR
MRK (Merck & Co., Inc.) and MSTR (Strategy Inc) are both stocks. MRK operates in Drug Manufacturers - General (Healthcare), while MSTR operates in Software - Application (Technology). Over the past 10 years, MRK returned 11.61%/yr vs 21.08%/yr for MSTR. At a 0.17 correlation, their price movements are largely independent.
Performance
MRK vs. MSTR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRK achieves a 14.39% return, which is significantly higher than MSTR's -16.29% return. Over the past 10 years, MRK has underperformed MSTR with an annualized return of 11.61%, while MSTR has yielded a comparatively higher 21.08% annualized return.
MRK
- 1D
- -1.05%
- 1M
- 7.31%
- YTD
- 14.39%
- 6M
- 22.75%
- 1Y
- 56.85%
- 3Y*
- 5.78%
- 5Y*
- 13.57%
- 10Y*
- 11.61%
MSTR
- 1D
- 5.61%
- 1M
- -32.19%
- YTD
- -16.29%
- 6M
- -30.75%
- 1Y
- -66.03%
- 3Y*
- 65.16%
- 5Y*
- 19.92%
- 10Y*
- 21.08%
MRK vs. MSTR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 14.39% | 9.79% | -6.26% | 1.01% | 49.42% | 1.75% | -7.20% | 22.27% | 39.95% | -1.49% |
MSTR Strategy Inc | -16.29% | -47.53% | 358.54% | 346.15% | -74.00% | 40.13% | 172.42% | 11.65% | -2.70% | -33.49% |
Correlation
The correlation between MRK and MSTR is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.00 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.00 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 1998 | 0.17 |
The correlation between MRK and MSTR shifts across timeframes, from -0.00 (3 years) to 0.17 (all time), reflecting how their relationship changes across market environments.
Fundamentals
MRK:
$295.45B
MSTR:
$42.47B
MRK:
$3.58
MSTR:
-$40.19
MRK:
4.54
MSTR:
79.74
MRK:
6.44
MSTR:
1.16
MRK:
$65.59B
MSTR:
$490.47M
MRK:
$49.79B
MSTR:
$334.08M
MRK:
$22.69B
MSTR:
$466.93M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRK vs. MSTR — Risk / Return Rank
MRK
MSTR
MRK vs. MSTR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Strategy Inc (MSTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MRK | MSTR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.03 | ||
| Sortino ratioReturn per unit of downside risk | +4.71 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 0.82 | +0.54 |
| Calmar ratioReturn relative to maximum drawdown | 5.03 | -0.86 | +5.89 |
| Martin ratioReturn relative to average drawdown | 12.59 | -1.27 | +13.86 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MRK | MSTR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.10 | -0.94 | +3.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.58 | 0.22 | +0.36 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | 0.29 | +0.22 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.12 | +0.36 |
Drawdowns
MRK vs. MSTR - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.61%, smaller than the maximum MSTR drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for MRK and MSTR.
Loading charts...
Drawdown Indicators
| MRK | MSTR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.61% | -99.86% | +31.25% |
Max Drawdown (1Y)Largest decline over 1 year | -11.37% | -76.53% | +65.16% |
Max Drawdown (3Y)Largest decline over 3 years | -43.44% | -77.42% | +33.98% |
Max Drawdown (5Y)Largest decline over 5 years | -43.44% | -84.11% | +40.67% |
Max Drawdown (10Y)Largest decline over 10 years | -43.44% | -89.27% | +45.83% |
Current DrawdownCurrent decline from peak | -4.65% | -73.15% | +68.50% |
Average DrawdownAverage peak-to-trough decline | -18.84% | -86.47% | +67.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 52.19% | -47.66% |
Volatility
MRK vs. MSTR - Volatility Comparison
The current volatility for Merck & Co., Inc. (MRK) is 9.44%, while Strategy Inc (MSTR) has a volatility of 21.43%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than MSTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRK | MSTR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.44% | 21.43% | -11.99% |
Volatility (6M)Calculated over the trailing 6-month period | 18.14% | 56.80% | -38.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.30% | 70.82% | -43.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.71% | 90.87% | -67.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.96% | 73.77% | -50.81% |
Dividends
MRK vs. MSTR - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 2.78%, while MSTR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 2.78% | 3.12% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% |
MSTR Strategy Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MRK vs. MSTR - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Strategy Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MRK and MSTR have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MSTR has higher volatility (21.43%) compared to MRK (9.44%). In terms of maximum drawdown, MRK dropped -68.61% vs MSTR's -99.86%.
MRK currently has the higher Sharpe Ratio (2.10 vs -0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRK and MSTR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer